Inside This Section

    AMCP Specialty Pharmacy Central

    Specialty Pharmacy 

    Welcome to Specialty Pharmacy Central, home to all of AMCP’s specialty pharmacy programs, materials and tools. Being the leader in this sector, the fastest growing in pharmaceuticals, is a top AMCP strategic priority – and includes our commitment to increasing awareness and understanding of specialty medicines, including biosimilars, among members, other managed care practitioners, policymakers, industry leaders and the public. 

     

    Managed Care Pharmacy at the Forefront

    Managed care pharmacists are taking key leadership roles within their organizations and in Congress, regulatory agencies and state capitals regarding the proper use and administration of specialty pharmaceuticals, which includes:  

    • Care management
    • Storage control and safe handling
    • Preparation
    • Administrative procedures
    • Distribution
    • Formulary development
    • Regulatory pathways 

    Biosimilars

    Biosimilars represent an opportunity to bend the cost curve for specialty drugs. AMCP believes the public and health care community’s adoption of biosimilars will be enhanced if we can assure them that biosimilars are being actively monitored for safety and effectiveness. Click here to access our new list of resources on Biosimilars and more information on the Biologics & Biosimilars Collective Intelligence Consortium. 

     

    Resources:

    Specialty Pharmacy Events 

         Specialty Pharmacy Connect - March 27, 2017, Denver, CO 

    Toolkits 

         Specialty Tier Toolkit 

         Oral Chemo Parity Toolkit 

    Position Statements 

         Biosimilar Position Statement 

         Government Mandates Position Statement 

    White Papers (The below concept is currently being reviewed by AMCP and revisions will be posted when Board approved.)  

         Concept Paper on Specialty Pharmaceuticals 

    Legislation & Regulation  (Members Only)

         Federal Trade Commission Follow-On Biologics Workshop: Impact of Recent Legislative and Regulatory Naming Proposals on Competition 

         Medicare Part D Program Releases Requirements for Biosimilar Products, March 2015 

         Federal Tracking Chart 

         Regulatory Tracking Chart 

    Specialty Pharmacy Industry Reports  

    Content for class "break" Goes Here